Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Cutaneous Lupus Erythematosus (CLE)

In brief

The goal of this clinical study is to test how edecesertib (formerly known as GS-5718) can be useful in treating Cutaneous Lupus Erythematosus (CLE) in participants with CLE. Information on what is happening in the body relating to CLE, how the body processes, is affected by and responds to the study drug, and any study drug side effects will also be collected in this study.

Key facts

Study ID
NCT05629208
Run by
Gilead Sciences
People needed
20
Starts
2023-04-17
Expected to finish
2026-01-14
Last updated by the study team
2026-02-17

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.